omega-Aminohexanoic acid · Eaca kabi · Acido aminocaproico · Acidum aminocaproicum · epsilon-Amino-n-hexanoic acid · Epsilon-aminocapronzuur. 6-aminohexanoic acid; 6-Aminocaproic acid; aminocaproic acid Source: Therapeutic Target Database (TTD) (D0FD0H) Deposit Date: Available. 6-Aminocaproic acid; 6-aminohexanoic acid; Acide aminocaproïque. Ácido aminocapróico. acidum aminocaproicum. Aminocaproic Acid; Aminocapronsäure .
|Published (Last):||14 February 2010|
|PDF File Size:||17.29 Mb|
|ePub File Size:||14.15 Mb|
|Price:||Free* [*Free Regsitration Required]|
Rusalatide acetate Aminocaproic Acid may increase the thrombogenic activities of Rusalatide acetate. Effectors of the activation of human [Glu1]plasminogen by human tissue plasminogen activator.
In adults, oral absorption appears to be a zero-order process with an absorption rate of 5. Views Read Edit View history. Subscribe to free Drugs. Impaired activation of the fibrinolytic system in children zcido Henoch-Schonlein purpura: Aminomethylbenzoic acid Aminocaproic Acid may increase the thrombogenic activities of Aminomethylbenzoic acid.
An intravenous infusion dose of 2.
Anti-inhibitor coagulant complex Aminocaproic Acid may increase the thrombogenic activities of Anti-inhibitor coagulant amminocaproico.
An antifibrinolytic agent that acts by inhibiting plasminogen activators which aminocapgoico fibrinolytic properties. Antihemophilic factor human Aminocaproic Acid may increase the thrombogenic activities of Antihemophilic factor human.
Drug Interaction Alphaproteinase inhibitor Alphaproteinase inhibitor may increase the thrombogenic activities of Aminocaproic Acid.
General Function Serine-type endopeptidase activity Specific Function Apo a is the main constituent of lipoprotein a Lp a.
Trenonacog alfa Aminocaproic Acid may increase the thrombogenic activities of Trenonacog alfa. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Emicizumab Aminocaproic Acid may increase the thrombogenic activities of Emicizumab. Analysis of plasmin binding and urokinase activation of plasminogen bound to the Heymann nephritis autoantigen, gp The Annals of Pharmacotherapy.
Aminocaproic acid | C6H13NO2 – PubChem
Absorbed rapidly following oral administration. A Tissue-type plasminogen activator.
Aminocaproic acid binds reversibly to the kringle domain of plasminogen aminoxaproico blocks the binding of plasminogen to fibrin and its activation to plasmin. This page was last edited on 26 Novemberat General Function Serine-type peptidase activity Specific Function Plasmin dissolves the fibrin of blood clots and acts as a proteolytic factor in a variety of other processes including embryonic development, tissue remodeling, tumor invasion, and inflammation.
Damoctocog alfa pegol Aminocaproixo Acid may increase the thrombogenic activities of Damoctocog alfa pegol.
Renal excretion is the primary route of elimination, whether aminocaproic acid is administered orally or intravenously. Inhibits tissue-type plasminogen activator 1. For this reason it is effective in treatment of certain bleeding disordersand it is marketed as Amicar.
Lipoprotein 9a a has two components, apolipoprotein B, linked to apolipoprotein a. Coagulation factor X human Aminocaproic Acid may increase the thrombogenic activities of Coagulation factor X human. Lp a may be a ligand for m Vatreptacog alfa Aminocaproic Acid may increase the thrombogenic activities of Vatreptacog alfa. By clicking Subscribe, I agree to the Drugs. General Function Serine-type endopeptidase activity Specific Function Converts the abundant, but inactive, zymogen plasminogen to plasmin by hydrolyzing a single Arg-Val bond in plasminogen.
Antihemophilic factor, human recombinant Aminocaproic Acid may increase the thrombogenic activities of Antihemophilic factor, human recombinant. By controlling plasmin-mediated proteolysis, it plays an important role in t The mean lag time in absorption is 10 minutes.